Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
暂无分享,去创建一个
Jung Hun Lee | B. Jeong | C. Cha | Young Bae Kim | Chang-Ro Lee | I. K. Bae | Kwang Seung Park | Moonhee Park | S. Lee
[1] P. Courvalin,et al. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. , 2017, Microbial drug resistance.
[2] Mostafizur Rahman,et al. Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia. , 2017, Microbial drug resistance.
[3] J. Mateos,et al. The FhaB/FhaC two-partner secretion system is involved in adhesion of Acinetobacter baumannii AbH12O-A2 strain , 2017, Virulence.
[4] P. Rather,et al. An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075 , 2016, Journal of bacteriology.
[5] R. Pathania,et al. Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter—AbaF , 2017, The Journal of antimicrobial chemotherapy.
[6] C. Landersdorfer,et al. High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii , 2017, The Journal of antimicrobial chemotherapy.
[7] M. Salem,et al. Investigation of the Virulence Factors and Molecular Characterization of the Clonal Relations of Multidrug-Resistant Acinetobacter baumannii Isolates. , 2017, Journal of AOAC International.
[8] M. Provinciali,et al. Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. , 2016, Diagnostic microbiology and infectious disease.
[9] A. S. Attia,et al. The secretome of Acinetobacter baumannii ATCC 17978 type II secretion system reveals a novel plasmid encoded phospholipase that could be implicated in lung colonization. , 2016, International journal of medical microbiology : IJMM.
[10] S. Kuo,et al. In vitro activity of SecA inhibitors in combination with carbapenems against carbapenem-hydrolysing class D β-lactamase-producing Acinetobacter baumannii. , 2016, The Journal of antimicrobial chemotherapy.
[11] C. Landersdorfer,et al. Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii. , 2016, International journal of antimicrobial agents.
[12] A. Tsakris,et al. First report of an NDM-1 metallo-β-lactamase-producing Acinetobacter baumannii clinical isolate in Greece. , 2016, International journal of antimicrobial agents.
[13] Łukasz Nierzwicki,et al. Correlation between the number of Pro-Ala repeats in the EmrA homologue of Acinetobacter baumannii and resistance to netilmicin, tobramycin, imipenem and ceftazidime. , 2016, Journal of global antimicrobial resistance.
[14] C. Rumbo,et al. Assessment of antivirulence activity of several d-amino acids against Acinetobacter baumannii and Pseudomonas aeruginosa. , 2016, The Journal of antimicrobial chemotherapy.
[15] M. Kempf,et al. First case of OXA-24-producing Acinetobacter baumannii in cattle from Reunion Island, France. , 2016, International journal of antimicrobial agents.
[16] R. Schmidt,et al. Iron-Regulated Phospholipase C Activity Contributes to the Cytolytic Activity and Virulence of Acinetobacter baumannii , 2016, PloS one.
[17] V. Nizet,et al. Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[18] Crhisllane Rafaele dos Santos Vasconcelos,et al. High Frequency of OXA-253-Producing Acinetobacter baumannii in Different Hospitals in Recife, Brazil , 2016, Antimicrobial Agents and Chemotherapy.
[19] Devin K Schweppe,et al. In vivo protein interaction network analysis reveals porin-localized antibiotic inactivation in Acinetobacter baumannii strain AB5075 , 2016, Nature Communications.
[20] M. Kempf,et al. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[21] Xiaofen Liu,et al. Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model. , 2016, International journal of antimicrobial agents.
[22] Neang S. Ly,et al. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies. , 2016, The Journal of antimicrobial chemotherapy.
[23] Sander K. Govers,et al. ‘Artilysation’ of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci , 2016, Scientific Reports.
[24] I. Kusradze,et al. Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent , 2016, Front. Microbiol..
[25] Eric P. Skaar,et al. Acinetobacter baumannii Coordinates Urea Metabolism with Metal Import To Resist Host-Mediated Metal Limitation , 2016, mBio.
[26] W. Wongpoowarak,et al. Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[27] D. Bumann,et al. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism , 2016, Antimicrobial Agents and Chemotherapy.
[28] Marion J. Skalweit,et al. Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms , 2016, Drug design, development and therapy.
[29] Amjad Ali,et al. Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets , 2016, BMC Genomics.
[30] S. Koren,et al. Diversity in a Polymicrobial Community Revealed by Analysis of Viromes, Endolysins and CRISPR Spacers , 2016, PloS one.
[31] S. Sitthisak,et al. Enhanced Antibacterial Activity of Acinetobacter baumannii Bacteriophage ØABP-01 Endolysin (LysABP-01) in Combination with Colistin , 2016, Front. Microbiol..
[32] S. Choi,et al. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[33] Neang S. Ly,et al. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii. , 2016, International journal of antimicrobial agents.
[34] D. Muthusamy,et al. Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant Acinetobacter baumannii at a Tertiary Care Hospital from South India. , 2016, Journal of clinical and diagnostic research : JCDR.
[35] K. Walia,et al. Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India , 2016, Infectious Diseases and Therapy.
[36] A. Tsakris,et al. In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates , 2016, Antimicrobial Agents and Chemotherapy.
[37] M. V. van Hoek,et al. Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii , 2016, BMC Microbiology.
[38] H. Balkhy,et al. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[39] K. Schulze,et al. Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis , 2016, Proceedings of the National Academy of Sciences.
[40] Iraida E. Robledo,et al. Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance. , 2016, Journal of medical microbiology.
[41] T. Naas,et al. First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia , 2016, Antimicrobial Agents and Chemotherapy.
[42] HasaniAlka,et al. Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran , 2016 .
[43] Xiaojiao Zhang,et al. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii. , 2016, Microbial pathogenesis.
[44] Clonal spread of blaOXA-72-carrying Acinetobacter baumannii sequence type 512 in Taiwan. , 2016, International journal of antimicrobial agents.
[45] Y. Cong,et al. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model , 2016, PloS one.
[46] C. Ryu,et al. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii , 2016, Scientific Reports.
[47] A. Flieger,et al. Bacterial Sphingomyelinases and Phospholipases as Virulence Factors , 2016, Microbiology and Molecular Reviews.
[48] Young Bae Kim,et al. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods , 2016, Front. Microbiol..
[49] Eric P. Skaar,et al. The Response of Acinetobacter baumannii to Zinc Starvation. , 2016, Cell host & microbe.
[50] G. Traglia,et al. Serum Albumin and Ca2+ Are Natural Competence Inducers in the Human Pathogen Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[51] C. McElheny,et al. In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains , 2016, Antimicrobial Agents and Chemotherapy.
[52] W. Jeng,et al. Single amino acid substitution Gly186Val in AdeS restores tigecycline susceptibility of Acinetobacter baumannii. , 2016, The Journal of antimicrobial chemotherapy.
[53] T. Naas,et al. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa. , 2016, Journal of global antimicrobial resistance.
[54] Y. Chen,et al. Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[55] T. Umland,et al. The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii , 2016, mSphere.
[56] J. Pachón,et al. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models , 2016, Antimicrobial Agents and Chemotherapy.
[57] C. Ryu,et al. In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357 , 2016, Applied and Environmental Microbiology.
[58] T. Parish,et al. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[59] Karl A. Hassan,et al. Rapid multiplexed phenotypic screening identifies drug resistance functions for three novel efflux pumps in Acinetobacter baumannii. , 2016, The Journal of antimicrobial chemotherapy.
[60] P. Zipfel,et al. CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein. , 2016, The Journal of infectious diseases.
[61] J. Mazucheli,et al. Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections. , 2016, International journal of antimicrobial agents.
[62] S. Jang,et al. Development and Evaluation of Species-Specific PCR for Detection of Nine Acinetobacter Species. , 2016, Annals of clinical and laboratory science.
[63] S. Kuo,et al. In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[64] B. Fu,et al. Characterization of surface antigen protein 1 (SurA1) from Acinetobacter baumannii and its role in virulence and fitness. , 2016, Veterinary microbiology.
[65] Mohit Kumar. Identification of a Novel NDM Variant, blaNDM-3, From a Multidrug-Resistant Acinetobacter baumannii , 2016, Infection Control & Hospital Epidemiology.
[66] K. Ko,et al. High rate of colistin dependence in Acinetobacter baumannii. , 2016, The Journal of antimicrobial chemotherapy.
[67] Brian T. Tsuji,et al. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[68] Brian T. Tsuji,et al. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance , 2016, Antimicrobial Agents and Chemotherapy.
[69] R. Bonomo,et al. Mutations Decreasing Intrinsic β-Lactam Resistance Are Linked to Cell Division in the Nosocomial Pathogen Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[70] J. Cooke. How to minimise antibiotic resistance. , 2016, The Lancet. Infectious diseases.
[71] X. Wang,et al. Molecular characterization of carbapenemase genes in Acinetobacter baumannii in China. , 2016, Genetics and molecular research : GMR.
[72] Sander K. Govers,et al. Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[73] Takashi Asahara,et al. Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model , 2016, Antimicrobial Agents and Chemotherapy.
[74] You-ning Liu,et al. Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria , 2016, Antimicrobial Agents and Chemotherapy.
[75] Weiwei Huang,et al. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii , 2016, Scientific Reports.
[76] Chad W. Euler,et al. Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii , 2016, Antimicrobial Agents and Chemotherapy.
[77] H. Barrios,et al. A Multicenter Study in Mexico Finds Acinetobacter baumannii Clinical Isolates Belonging to Clonal Complexes 636B (113B) and 92B Harboring OXA-72, OXA-239, and OXA-469 , 2016, Antimicrobial Agents and Chemotherapy.
[78] Eric P. Skaar,et al. Medically Relevant Acinetobacter Species Require a Type II Secretion System and Specific Membrane-Associated Chaperones for the Export of Multiple Substrates and Full Virulence , 2016, PLoS pathogens.
[79] M. Rahmati-Yamchi,et al. Frequency of Aminoglycoside-Modifying Enzymes and ArmA Among Different Sequence Groups of Acinetobacter baumannii in Iran. , 2016, Microbial drug resistance.
[80] Brent S. Weber,et al. Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond , 2015, Journal of bacteriology.
[81] H. Wei,et al. Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa , 2015, Front. Microbiol..
[82] H. Mobley,et al. Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness , 2015, Journal of bacteriology.
[83] M. Al-Haroni,et al. Imipenem Treatment Induces Expression of Important Genes and Phenotypes in a Resistant Acinetobacter baumannii Isolate , 2015, Antimicrobial Agents and Chemotherapy.
[84] I. Mitroulis,et al. Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps , 2015, Antimicrobial Agents and Chemotherapy.
[85] M. McConnell,et al. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii. , 2015, International journal of antimicrobial agents.
[86] L. Peterson,et al. Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii , 2015, mBio.
[87] J. Barbé,et al. Novobiocin Inhibits the Antimicrobial Resistance Acquired through DNA Damage-Induced Mutagenesis in Acinetobacter baumannii , 2015, Antimicrobial Agents and Chemotherapy.
[88] V. Srinivasan,et al. Functional Characterization of AbeD, an RND-Type Membrane Transporter in Antimicrobial Resistance in Acinetobacter baumannii , 2015, PloS one.
[89] Y. Shamoo,et al. Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance , 2015, PloS one.
[90] E. Mylonakis,et al. Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology , 2015, Antimicrobial Agents and Chemotherapy.
[91] J. Reymond,et al. In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa , 2015, Antimicrobial Agents and Chemotherapy.
[92] Kelsey A. Gregg,et al. A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii , 2015, Antimicrobial Agents and Chemotherapy.
[93] C. Vay,et al. In vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates. , 2015, Journal of medical microbiology.
[94] R. Relich,et al. Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes , 2015, Antimicrobial Agents and Chemotherapy.
[95] A. Viale,et al. Differential Role of the T6SS in Acinetobacter baumannii Virulence , 2015, PloS one.
[96] I. Ebersberger,et al. Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D , 2015, PloS one.
[97] Ming-Hsien Chiang,et al. Acinetobacter baumannii Extracellular OXA-58 Is Primarily and Selectively Released via Outer Membrane Vesicles after Sec-Dependent Periplasmic Translocation , 2015, Antimicrobial Agents and Chemotherapy.
[98] J. Córdoba,et al. In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii , 2015, Antimicrobial Agents and Chemotherapy.
[99] Woojun Park,et al. Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii , 2015, PloS one.
[100] Yongrui Liu,et al. Detection of AmpC β-lactamases in Acinetobacter baumannii in the Xuzhou region and analysis of drug resistance. , 2015, Experimental and therapeutic medicine.
[101] C. Hou,et al. Drug-resistant gene of blaOXA-23, blaOXA-24, blaOXA-51 and blaOXA-58 in Acinetobacter baumannii. , 2015, International journal of clinical and experimental medicine.
[102] Jung Hun Lee,et al. Quantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic review , 2015, Front. Microbiol..
[103] Jung Hun Lee,et al. Urgent need for β-lactam-β-lactamase inhibitors. , 2015, The Lancet. Infectious diseases.
[104] P. Zipfel,et al. Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein , 2015, PloS one.
[105] S. Pukatzki,et al. A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii , 2015, Proceedings of the National Academy of Sciences.
[106] J. Picazo,et al. Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii? , 2015, Antimicrobial Agents and Chemotherapy.
[107] Ming-Feng Lin,et al. The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii , 2015, PloS one.
[108] E. Santillana,et al. Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System , 2015, PloS one.
[109] Jie-ping Zhu,et al. Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump , 2015, Antimicrobial Agents and Chemotherapy.
[110] V. Tam,et al. Risk factors for nephrotoxicity onset associated with polymyxin B therapy. , 2015, The Journal of antimicrobial chemotherapy.
[111] Dao-jun Yu,et al. In vitro and in vivo analysis of antimicrobial agents alone and in combination against multi-drug resistant Acinetobacter baumannii , 2015, Front. Microbiol..
[112] J. Brodbelt,et al. Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival , 2015, mBio.
[113] D. Wareham,et al. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections , 2015, Antimicrobial Agents and Chemotherapy.
[114] Jung Hun Lee,et al. Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance , 2015, International journal of molecular sciences.
[115] Zhongdao Wu,et al. Outer membrane vesicles isolated from two clinical Acinetobacter baumannii strains exhibit different toxicity and proteome characteristics. , 2015, Microbial pathogenesis.
[116] Kazuaki Matsumoto,et al. Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: dosing considerations for Acinetobacter baumannii infections. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[117] Cary L. Honnold,et al. Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[118] R. Isberg,et al. Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii , 2015, PLoS pathogens.
[119] Y. Li,et al. Clonal dissemination of extensively drug-resistant Acinetobacter baumannii producing an OXA-23 β-lactamase at a teaching hospital in Shanghai, China. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[120] A. Peleg,et al. Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options , 2015, Seminars in Respiratory and Critical Care Medicine.
[121] K. Ko,et al. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin , 2015, Journal of Microbiology.
[122] M. Blokesch,et al. The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer , 2015, Science.
[123] A. S. Attia,et al. Acinetobacter baumannii universal stress protein A plays a pivotal role in stress response and is essential for pneumonia and sepsis pathogenesis. , 2015, International journal of medical microbiology : IJMM.
[124] Y. Yu,et al. Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC, encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase , 2015, European Journal of Clinical Microbiology & Infectious Diseases.
[125] Ming-Feng Lin,et al. Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. , 2014, World journal of clinical cases.
[126] BakourSofiane,et al. Characterization of Acinetobacter baumannii Clinical Isolates Carrying blaOXA-23 Carbapenemase and 16S rRNA Methylase armA genes in Yemen , 2014 .
[127] J. Rolain,et al. Characterization of Acinetobacter baumannii clinical isolates carrying bla(OXA-23) carbapenemase and 16S rRNA methylase armA genes in Yemen. , 2014, Microbial drug resistance.
[128] D. Ritchie,et al. A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[129] Ronald N. Jones,et al. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[130] A. Chapeaurouge,et al. Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach , 2014, Proteomics. Clinical applications.
[131] M. Touchon,et al. The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences , 2014, Genome biology and evolution.
[132] C. Tang,et al. Prevalence and mapping of a plasmid encoding a type IV secretion system in Acinetobacter baumannii. , 2014, Genomics.
[133] Katherina C. Chua,et al. Whole-Genome Sequence Analysis of the Naturally Competent Acinetobacter baumannii Clinical Isolate A118 , 2014, Genome biology and evolution.
[134] N. Soares,et al. The Acinetobacter baumannii Omp33-36 Porin Is a Virulence Factor That Induces Apoptosis and Modulates Autophagy in Human Cells , 2014, Infection and Immunity.
[135] P. Dunman,et al. Identification of Acinetobacter baumannii Serum-Associated Antibiotic Efflux Pump Inhibitors , 2014, Antimicrobial Agents and Chemotherapy.
[136] Christian Cambillau,et al. Architecture and assembly of the Type VI secretion system. , 2014, Biochimica et biophysica acta.
[137] T. P. G. Chagas,et al. Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79). , 2014, Diagnostic microbiology and infectious disease.
[138] C. Tang,et al. The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[139] J. Cannon,et al. The risk of seizures among the carbapenems: a meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.
[140] A. Peleg,et al. A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. , 2014, The Journal of infectious diseases.
[141] G. Volckaert,et al. Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens , 2014, mBio.
[142] Bin Chen,et al. Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models , 2014, PloS one.
[143] G. Rossolini,et al. Epidemic Diffusion of OXA-23-Producing Acinetobacter baumannii Isolates in Italy: Results of the First Cross-Sectional Countrywide Survey , 2014, Journal of Clinical Microbiology.
[144] Chuanmin Tao,et al. Efficacy and Safety of Polymyxins for the Treatment of Acinectobacter baumannii Infection: A Systematic Review and Meta-Analysis , 2014, PloS one.
[145] Mark J. Mandel,et al. Genome-Wide Identification of Acinetobacter baumannii Genes Necessary for Persistence in the Lung , 2014, mBio.
[146] T. Kirikae,et al. Dissemination of 16S rRNA Methylase ArmA-Producing Acinetobacter baumannii and Emergence of OXA-72 Carbapenemase Coproducers in Japan , 2014, Antimicrobial Agents and Chemotherapy.
[147] Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[148] Federico Perez,et al. New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis , 2014, mBio.
[149] Xi Li,et al. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase. , 2014, The Journal of antimicrobial chemotherapy.
[150] Ming-Feng Lin,et al. Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility , 2014, BMC Microbiology.
[151] A. Akin,et al. Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia , 2014, Infection.
[152] J. Vila,et al. Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.
[153] Andrés Magán,et al. Role of Acinetobacter baumannii UmuD Homologs in Antibiotic Resistance Acquired through DNA Damage-Induced Mutagenesis , 2013, Antimicrobial Agents and Chemotherapy.
[154] Mayumi Yoshida,et al. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[155] P. Nordmann,et al. TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii. , 2013, The Journal of antimicrobial chemotherapy.
[156] D. Nicolau,et al. In Vitro Pharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.
[157] C. Taitt,et al. Antimicrobial Resistance Determinants in Acinetobacter baumannii Isolates Taken from Military Treatment Facilities , 2013, Antimicrobial Agents and Chemotherapy.
[158] J. Pachón,et al. Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii. , 2013, The Journal of infectious diseases.
[159] A. Vicente,et al. Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene , 2013, BMC Microbiology.
[160] Jung Hun Lee,et al. Lipid a biosynthesis of multidrug-resistant pathogens - a novel drug target. , 2013, Current pharmaceutical design.
[161] J. Sheng,et al. Molecular Epidemiology and Mechanisms of Tigecycline Resistance in Clinical Isolates of Acinetobacter baumannii from a Chinese University Hospital , 2013, Antimicrobial Agents and Chemotherapy.
[162] A. di Caro,et al. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection. , 2013, Microbial drug resistance.
[163] Nichollas E. Scott,et al. A common pathway for O‐linked protein‐glycosylation and synthesis of capsule in Acinetobacter baumannii , 2013, Molecular microbiology.
[164] Sang Hee Lee,et al. Strategies to Minimize Antibiotic Resistance , 2013, International journal of environmental research and public health.
[165] Je Chul Lee,et al. Acinetobacter baumannii Outer Membrane Vesicles Elicit a Potent Innate Immune Response via Membrane Proteins , 2013, PloS one.
[166] J. Mekalanos,et al. PAAR-repeat proteins sharpen and diversify the Type VI secretion system spike , 2013, Nature.
[167] B. Liu,et al. Diversity in the Major Polysaccharide Antigen of Acinetobacter Baumannii Assessed by DNA Sequencing, and Development of a Molecular Serotyping Scheme , 2013, PloS one.
[168] J. Vila,et al. Globally Expanding Carbapenemase Finally Appears in Spain: Nosocomial Outbreak of Acinetobacter baumannii Producing Plasmid-Encoded OXA-23 in Barcelona, Spain , 2013, Antimicrobial Agents and Chemotherapy.
[169] Jace W. Jones,et al. Unique Structural Modifications Are Present in the Lipopolysaccharide from Colistin-Resistant Strains of Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.
[170] Ming-Feng Lin,et al. Molecular Epidemiology of Integron-Associated Antimicrobial Gene Cassettes in the Clinical Isolates of Acinetobacter baumannii from Northern Taiwan , 2013, Annals of laboratory medicine.
[171] Kyudong Han,et al. Co-existence of blaOXA-23 and armA in multidrug-resistant Acinetobacter baumannii isolated from a hospital in South Korea. , 2013, Journal of medical microbiology.
[172] C. Landersdorfer,et al. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[173] R. Hall,et al. Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes , 2013, PloS one.
[174] Y.-T. Lee,et al. Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[175] G. Bou,et al. Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World? , 2013, Clinical Microbiology Reviews.
[176] R. Munson,et al. Acinetobacter baumannii Utilizes a Type VI Secretion System for Bacterial Competition , 2013, PloS one.
[177] R. Saha,et al. Microbial siderophores: a mini review , 2013, Journal of basic microbiology.
[178] M. McConnell,et al. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. , 2013, FEMS microbiology reviews.
[179] C. Wolz,et al. Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus. , 2013, The Journal of antimicrobial chemotherapy.
[180] P. Higgins,et al. OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.
[181] J. Mekalanos,et al. Tit-for-Tat: Type VI Secretion System Counterattack during Bacterial Cell-Cell Interactions , 2013, Cell.
[182] Eric P. Skaar,et al. Genomic and Functional Analysis of the Type VI Secretion System in Acinetobacter , 2013, PloS one.
[183] V. Godoy,et al. Antibiotic Resistance Acquired through a DNA Damage-Inducible Response in Acinetobacter baumannii , 2013, Journal of bacteriology.
[184] Nicole R. Luke-Marshall,et al. The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization , 2013, Infection and Immunity.
[185] R. Bonomo,et al. Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. , 2013, Vaccine.
[186] Eric P. Skaar,et al. Identification of an Acinetobacter baumannii Zinc Acquisition System that Facilitates Resistance to Calprotectin-mediated Zinc Sequestration , 2012, PLoS pathogens.
[187] Ming-Chin Chan,et al. A Truncated AdeS Kinase Protein Generated by ISAba1 Insertion Correlates with Tigecycline Resistance in Acinetobacter baumannii , 2012, PloS one.
[188] M. Almuzara,et al. Emergence and Spread of Plasmid-Borne tet(B)::ISCR2 in Minocycline-Resistant Acinetobacter baumannii Isolates , 2012, Antimicrobial Agents and Chemotherapy.
[189] A. Rakin,et al. Hunger for iron: the alternative siderophore iron scavenging systems in highly virulent Yersinia , 2012, Front. Cell. Inf. Microbio..
[190] M. Adams,et al. Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis , 2012, mBio.
[191] M. Sunbul,et al. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii. , 2012, International journal of antimicrobial agents.
[192] P. Visca,et al. In Vitro and In Vivo Antimicrobial Activities of Gallium Nitrate against Multidrug-Resistant Acinetobacter baumannii , 2012, Antimicrobial Agents and Chemotherapy.
[193] F. Kokturk,et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia , 2012, Epidemiology and Infection.
[194] K. Seme,et al. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[195] S. Kuo,et al. Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: Nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program , 2012, BMC Infectious Diseases.
[196] T. Umland,et al. In Vivo-Validated Essential Genes Identified in Acinetobacter baumannii by Using Human Ascites Overlap Poorly with Essential Genes Detected on Laboratory Media , 2012, mBio.
[197] P. Higgins,et al. Molecular Epidemiology of Acinetobacter baumannii Bloodstream Isolates Obtained in the United States from 1995 to 2004 Using rep-PCR and Multilocus Sequence Typing , 2012, Journal of Clinical Microbiology.
[198] G. Pier,et al. Evaluation of the Trimeric Autotransporter Ata as a Vaccine Candidate against Acinetobacter baumannii Infections , 2012, Infection and Immunity.
[199] Rui Wang,et al. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. , 2012, The Journal of antimicrobial chemotherapy.
[200] D. Zurawski,et al. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility , 2012, Journal of Microbiology.
[201] Nichollas E. Scott,et al. Identification of a General O-linked Protein Glycosylation System in Acinetobacter baumannii and Its Role in Virulence and Biofilm Formation , 2012, PLoS pathogens.
[202] E. Sugawara,et al. OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii , 2012, Journal of bacteriology.
[203] C. Hsiung,et al. Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial Usage , 2012, PloS one.
[204] G. Pier,et al. Identification of Ata, a Multifunctional Trimeric Autotransporter of Acinetobacter baumannii , 2012, Journal of bacteriology.
[205] L. Actis,et al. The Acinetobacter baumannii entA Gene Located Outside the Acinetobactin Cluster Is Critical for Siderophore Production, Iron Acquisition and Virulence , 2012, PloS one.
[206] F. Luzzaro,et al. Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmA. , 2012, Journal of medical microbiology.
[207] W. Hol,et al. The type II secretion system: biogenesis, molecular architecture and mechanism , 2012, Nature Reviews Microbiology.
[208] M. McConnell,et al. Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells , 2012, PloS one.
[209] Samuel M. Greer,et al. Stress Response and Virulence Functions of the Acinetobacter baumannii NfuA Fe-S Scaffold Protein , 2012, Journal of bacteriology.
[210] Ayush Kumar,et al. Growth phase-dependent expression of RND efflux pump- and outer membrane porin-encoding genes in Acinetobacter baumannii ATCC 19606. , 2012, The Journal of antimicrobial chemotherapy.
[211] K. Ko,et al. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates. , 2012, Journal of medical microbiology.
[212] Gilbert GREUB,et al. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. , 2012, FEMS microbiology reviews.
[213] Chul Hee Choi,et al. Acinetobacter baumannii outer membrane protein a modulates the biogenesis of outer membrane vesicles , 2012, The Journal of Microbiology.
[214] P. Courvalin,et al. Expression of the Resistance-Nodulation-Cell Division Pump AdeIJK in Acinetobacter baumannii Is Regulated by AdeN, a TetR-Type Regulator , 2012, Antimicrobial Agents and Chemotherapy.
[215] Ming-Feng Lin,et al. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan. , 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[216] M. Adams,et al. Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection , 2012, PloS one.
[217] J. Gaddy,et al. Role of Acinetobactin-Mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii Strain ATCC 19606T with Human Lung Epithelial Cells, Galleria mellonella Caterpillars, and Mice , 2012, Infection and Immunity.
[218] Naohisa Matsunaga,et al. [Acinetobacter spp]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.
[219] S. Pournaras,et al. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). , 2011, The Journal of antimicrobial chemotherapy.
[220] J. Pachón,et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like. , 2011, International journal of antimicrobial agents.
[221] S. Ichiyama,et al. Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. , 2011, The Journal of antimicrobial chemotherapy.
[222] P. Nordmann,et al. Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[223] P. Nordmann,et al. Genetic Features of CTX-M-15-Producing Acinetobacter baumannii from Haiti , 2011, Antimicrobial Agents and Chemotherapy.
[224] P. Nordmann,et al. Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. , 2011, The Journal of antimicrobial chemotherapy.
[225] R. Bonomo,et al. Genetic analysis of surface motility in Acinetobacter baumannii. , 2011, Microbiology.
[226] J. Kaplan. Antibiotic-Induced Biofilm Formation , 2011, The International journal of artificial organs.
[227] T. Wichelhaus,et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. , 2011, The Journal of antimicrobial chemotherapy.
[228] H. Goossens,et al. Dissemination of an NDM-2-Producing Acinetobacter baumannii Clone in an Israeli Rehabilitation Center , 2011, Antimicrobial Agents and Chemotherapy.
[229] M. McConnell,et al. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. , 2011, Vaccine.
[230] P. Visca,et al. Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity , 2011, PloS one.
[231] Yee-Chun Chen,et al. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU. , 2011, Diagnostic microbiology and infectious disease.
[232] K. Garey,et al. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. , 2011, The Southeast Asian journal of tropical medicine and public health.
[233] N. Loman,et al. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. , 2011, The Journal of antimicrobial chemotherapy.
[234] L. Dijkshoorn,et al. Acinetobacter calcoaceticus–Acinetobacter baumannii complex species in clinical specimens in Singapore , 2011, Epidemiology and Infection.
[235] R. Hancock,et al. The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A , 2011, Antimicrobial Agents and Chemotherapy.
[236] J. Barbé,et al. Acinetobacter baumannii RecA Protein in Repair of DNA Damage, Antimicrobial Resistance, General Stress Response, and Virulence , 2011, Journal of bacteriology.
[237] G. Bou,et al. Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain , 2011, Emerging infectious diseases.
[238] Ming-Feng Lin,et al. Molecular epidemiology and antimicrobial resistance determinants of multidrug-resistant Acinetobacter baumannii in five proximal hospitals in Taiwan. , 2011, Japanese journal of infectious diseases.
[239] N. Woodford,et al. Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System , 2011, Antimicrobial Agents and Chemotherapy.
[240] N. Gordon,et al. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. , 2011, The Journal of antimicrobial chemotherapy.
[241] J. Li,et al. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients , 2011, BMC infectious diseases.
[242] N. Soares,et al. Horizontal Transfer of the OXA-24 Carbapenemase Gene via Outer Membrane Vesicles: a New Mechanism of Dissemination of Carbapenem Resistance Genes in Acinetobacter baumannii , 2011, Antimicrobial Agents and Chemotherapy.
[243] S. I. Kim,et al. Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection , 2011, Epidemiology and Infection.
[244] D. Wareham,et al. In Vivo Efficacy of Glycopeptide-Colistin Combination Therapies in a Galleria mellonella Model of Acinetobacter baumannii Infection , 2011, Antimicrobial Agents and Chemotherapy.
[245] I. Goic-Barisic,et al. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. , 2011, The Journal of hospital infection.
[246] P. Nordmann,et al. PER-7, an Extended-Spectrum β-Lactamase with Increased Activity toward Broad-Spectrum Cephalosporins in Acinetobacter baumannii , 2011, Antimicrobial Agents and Chemotherapy.
[247] Je Chul Lee,et al. Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles , 2011, PloS one.
[248] Ming-Feng Lin,et al. Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[249] X. H. Liu,et al. Genet. Mol. Res. , 2011 .
[250] Yunsong Yu,et al. Emergence of NDM-1-producing Acinetobacter baumannii in China. , 2011, The Journal of antimicrobial chemotherapy.
[251] P. Courvalin,et al. Efflux-Mediated Antibiotic Resistance in Acinetobacter spp , 2010, Antimicrobial Agents and Chemotherapy.
[252] Mina Kim,et al. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. , 2010, Diagnostic microbiology and infectious disease.
[253] A. Viale,et al. ISAba825, a Functional Insertion Sequence Modulating Genomic Plasticity and bla OXA-58 Expression in Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[254] B. Özbek,et al. Postantibiotic Effects of Tigecycline, Colistin Sulfate, and Levofloxacin Alone or Tigecycline-Colistin Sulfate and Tigecycline-Levofloxacin Combinations against Acinetobacter baumannii , 2010, Chemotherapy.
[255] Ronald N. Jones,et al. Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009). , 2010, Diagnostic microbiology and infectious disease.
[256] Ming-Feng Lin,et al. Role of integrons in antimicrobial susceptibility patterns of Acinetobacter baumannii. , 2010, Japanese journal of infectious diseases.
[257] D. Yong,et al. A Novel Insertion Sequence, ISAba10, Inserted into ISAba1 Adjacent to the bla OXA-23 Gene and Disrupting the Outer Membrane Protein Gene carO in Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[258] P. Krishnan,et al. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. , 2010, The Journal of antimicrobial chemotherapy.
[259] M. Kuehn,et al. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. , 2010, Annual review of microbiology.
[260] Jian Li,et al. Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production , 2010, Antimicrobial Agents and Chemotherapy.
[261] D. Gage,et al. Characterization of a Two-Component Regulatory System That Regulates Succinate-Mediated Catabolite Repression in Sinorhizobium meliloti , 2010, Journal of bacteriology.
[262] V. Srinivasan,et al. Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.
[263] P. Nordmann,et al. GES Extended-Spectrum β-Lactamases in Acinetobacter baumannii Isolates in Belgium , 2010, Antimicrobial Agents and Chemotherapy.
[264] S. Kuo,et al. Emergence and Distribution of Plasmids Bearing the blaOXA-51-Like Gene with an Upstream ISAba1 in Carbapenem-Resistant Acinetobacter baumannii Isolates in Taiwan , 2010, Antimicrobial Agents and Chemotherapy.
[265] P. Courvalin,et al. Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[266] T. Umland,et al. The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor , 2010, Infection and Immunity.
[267] Chul Hee Choi,et al. Acinetobacter baumannii outer membrane protein a induces dendritic cell death through mitochondrial targeting , 2010, The Journal of Microbiology.
[268] J. Quinn,et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.
[269] E. Culebras,et al. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. , 2010, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[270] A. Koster,et al. Do Biofilm Formation and Interactions with Human Cells Explain the Clinical Success of Acinetobacter baumannii? , 2010, PloS one.
[271] S. Amyes,et al. Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes , 2010, Journal of Clinical Microbiology.
[272] G. Bou,et al. OXA-24 Carbapenemase Gene Flanked by XerC/XerD-Like Recombination Sites in Different Plasmids from Different Acinetobacter Species Isolated during a Nosocomial Outbreak , 2010, Antimicrobial Agents and Chemotherapy.
[273] Laura Camarena,et al. Molecular Mechanisms of Ethanol-Induced Pathogenesis Revealed by RNA-Sequencing , 2010, PLoS pathogens.
[274] N. Gordon,et al. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. , 2010, International journal of antimicrobial agents.
[275] M. Kuehn,et al. Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles , 2010, Microbiology and Molecular Biology Reviews.
[276] E. Vinogradov,et al. Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis , 2010, Infection and Immunity.
[277] Eric P. Skaar,et al. Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis , 2010, Infection and Immunity.
[278] R. López-Rojas,et al. Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[279] M. Tolmasky,et al. Naturally Competent Acinetobacter baumannii Clinical Isolate as a Convenient Model for Genetic Studies , 2010, Journal of Clinical Microbiology.
[280] F. Donnarumma,et al. Molecular Characterization of Acinetobacter Isolates Collected in Intensive Care Units of Six Hospitals in Florence, Italy, during a 3-Year Surveillance Program: a Population Structure Analysis , 2010, Journal of Clinical Microbiology.
[281] C. Vay,et al. In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones. , 2010, Journal of infection in developing countries.
[282] Ming-Feng Lin,et al. Distribution of blaOXA-carrying imipenem-resistant Acinetobacter spp. in 3 hospitals in Taiwan. , 2010, Diagnostic microbiology and infectious disease.
[283] K. Ozdemir,et al. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii , 2010, The Journal of Antibiotics.
[284] C. Dhiraputra,et al. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii. , 2010, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[285] R. López-Rojas,et al. Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[286] P. Nordmann,et al. Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii1 , 2010, Emerging infectious diseases.
[287] Iraida E. Robledo,et al. Detection of KPC in Acinetobacter spp. in Puerto Rico , 2009, Antimicrobial Agents and Chemotherapy.
[288] Eric P. Skaar,et al. Acinetobacter baumannii Increases Tolerance to Antibiotics in Response to Monovalent Cations , 2009, Antimicrobial Agents and Chemotherapy.
[289] Jordi Rello,et al. International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.
[290] Chul Hee Choi,et al. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. , 2009, FEMS microbiology letters.
[291] N. Prasadarao,et al. CTX-M β-Lactamase Production and Virulence of Escherichia coli K1 , 2009, Emerging infectious diseases.
[292] M. S. Ramírez,et al. Novel Insights about Class 2 Integrons from Experimental and Genomic Epidemiology , 2009, Antimicrobial Agents and Chemotherapy.
[293] H. Rüden,et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. , 2009, Journal of medical microbiology.
[294] A. Papa,et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established Greek hospital. , 2009, Microbial drug resistance.
[295] J. Wu,et al. A novel aminoglycoside-modifying enzyme gene aac(6')-Ib in a pandrug-resistant Acinetobacter baumannii strain. , 2009, The Journal of hospital infection.
[296] P. Nordmann,et al. OXA-143, a Novel Carbapenem-Hydrolyzing Class D β-Lactamase in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.
[297] V. Srinivasan,et al. Role of AbeS, a Novel Efflux Pump of the SMR Family of Transporters, in Resistance to Antimicrobial Agents in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.
[298] H. Kim,et al. Loss of the 29-kilodalton outer membrane protein in the presence of OXA-51-like enzymes in Acinetobacter baumannii is associated with decreased imipenem susceptibility. , 2009, Microbial drug resistance.
[299] P. Nordmann,et al. ISCR2, Another Vehicle for blaVEB Gene Acquisition , 2009, Antimicrobial Agents and Chemotherapy.
[300] Y. Gho,et al. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. , 2009, FEMS microbiology letters.
[301] J. Vila,et al. CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.
[302] M. Adams,et al. Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System , 2009, Antimicrobial Agents and Chemotherapy.
[303] Chul Hee Choi,et al. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. , 2009, Diagnostic microbiology and infectious disease.
[304] J. Gaddy,et al. The Acinetobacter baumannii 19606 OmpA Protein Plays a Role in Biofilm Formation on Abiotic Surfaces and in the Interaction of This Pathogen with Eukaryotic Cells , 2009, Infection and Immunity.
[305] P. Courvalin,et al. GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.
[306] P. Nordmann,et al. Genetic and Biochemical Characterization of the First Extended-Spectrum CARB-Type ß-Lactamase, RTG-4, from Acinetobacter baumannii , 2009, Antimicrobial Agents and Chemotherapy.
[307] A. Agodi,et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. , 2009, The Journal of antimicrobial chemotherapy.
[308] N. Gordon,et al. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. , 2009, The Journal of antimicrobial chemotherapy.
[309] N. Woodford,et al. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. , 2009, The Journal of antimicrobial chemotherapy.
[310] T. Umland,et al. Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. , 2009, The Journal of infectious diseases.
[311] P. Visca,et al. Annals of Clinical Microbiology and , 2009 .
[312] D. Nicolau,et al. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model. , 2008, The Journal of antimicrobial chemotherapy.
[313] Ronald N. Jones,et al. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. , 2008, The Journal of antimicrobial chemotherapy.
[314] Jay Steingrub,et al. International study of the prevalence and outcomes of infection in intensive care units , 2009 .
[315] P. White,et al. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. , 2009, The Journal of antimicrobial chemotherapy.
[316] J. Bartlett,et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[317] Chul Hee Choi,et al. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells , 2008, BMC Microbiology.
[318] Yen-Hsu Chen,et al. Molecular characterisation of the metallo-beta-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. , 2008, International journal of antimicrobial agents.
[319] J. Gaddy,et al. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. , 2008, Microbiology.
[320] M. Adams,et al. Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii , 2008, Journal of bacteriology.
[321] Jien-Wei Liu,et al. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. , 2008, Microbial drug resistance.
[322] J. Noh,et al. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. , 2008, International journal of antimicrobial agents.
[323] A. Oliver,et al. Benefit of Having Multiple ampD Genes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa , 2008, Antimicrobial Agents and Chemotherapy.
[324] Harald Seifert,et al. Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.
[325] P. Higgins,et al. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[326] Y. Carmeli,et al. Extended-Spectrum β-Lactamase Production Is Associated with an Increase in Cell Invasion and Expression of Fimbrial Adhesins in Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.
[327] E. S. Moland,et al. In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy , 2008, Antimicrobial Agents and Chemotherapy.
[328] A. Tsakris,et al. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[329] F. Fernández,et al. Tigecycline for Acinetobacter baumannii infection: other considerations. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[330] Te‐Li Chen,et al. Acquisition of a Plasmid-Borne blaOXA-58 Gene with an Upstream IS1008 Insertion Conferring a High Level of Carbapenem Resistance to Acinetobacter baumannii , 2008, Antimicrobial Agents and Chemotherapy.
[331] J. Vila,et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[332] P. Nordmann,et al. Carbapenem-Resistant Acinetobacter baumannii Isolates from Tunisia Producing the OXA-58-Like Carbapenem-Hydrolyzing Oxacillinase OXA-97 , 2008, Antimicrobial Agents and Chemotherapy.
[333] Eric P. Skaar,et al. Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses , 2008, Science.
[334] D. Linkin,et al. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[335] S. Magnet,et al. AdeIJK, a Resistance-Nodulation-Cell Division Pump Effluxing Multiple Antibiotics in Acinetobacter baumannii , 2008, Antimicrobial Agents and Chemotherapy.
[336] C. Qi,et al. Characterization of Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Clinical Strains Collected from 2004 to 2007 , 2008, Journal of Clinical Microbiology.
[337] M. Bassetti,et al. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. , 2007, The Journal of antimicrobial chemotherapy.
[338] Chul Hee Choi,et al. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity , 2007, Cellular microbiology.
[339] A. Viale,et al. CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for l‐ornithine uptake , 2007, FEBS letters.
[340] J. Vila,et al. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[341] Jian Li,et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. , 2007, The Journal of antimicrobial chemotherapy.
[342] P. Nordmann,et al. Panresistant extended-spectrum beta-lactamase SHV-5-producing Acinetobacter baumannii from New York City. , 2007, The Journal of antimicrobial chemotherapy.
[343] S. Amyes,et al. Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[344] H. Seifert,et al. Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.
[345] C. Murray,et al. Development of Colistin-Dependent Acinetobacter baumannii-Acinetobacter calcoaceticus Complex , 2007, Antimicrobial Agents and Chemotherapy.
[346] Qiwen Yang,et al. Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese Hospitals , 2007, Antimicrobial Agents and Chemotherapy.
[347] Wensi S. Hu,et al. An OXA-66/OXA-51-Like Carbapenemase and Possibly an Efflux Pump Are Associated with Resistance to Imipenem in Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.
[348] Qing Yang,et al. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. , 2007, The Journal of antimicrobial chemotherapy.
[349] Stephen G. J. Smith,et al. A molecular Swiss army knife: OmpA structure, function and expression. , 2007, FEMS microbiology letters.
[350] R. Bonomo,et al. Global Challenge of Multidrug-Resistant Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.
[351] L. Peixe,et al. Molecular Epidemiology of Imipenem-Resistant Acinetobacter haemolyticus and Acinetobacter baumannii Isolates Carrying Plasmid-Mediated OXA-40 from a Portuguese Hospital , 2007, Antimicrobial Agents and Chemotherapy.
[352] P. Bradford,et al. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. , 2007, The Journal of antimicrobial chemotherapy.
[353] D. Paterson,et al. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.
[354] P. Nordmann,et al. Identification of the Novel Narrow-Spectrum β-Lactamase SCO-1 in Acinetobacter spp. from Argentina , 2007, Antimicrobial Agents and Chemotherapy.
[355] R. Bonomo,et al. Spread in an Italian Hospital of a Clonal Acinetobacter baumannii Strain Producing the TEM-92 Extended-Spectrum β-Lactamase , 2007, Antimicrobial Agents and Chemotherapy.
[356] L. Hsu,et al. IMP-4 and OXA β-lactamases in Acinetobacter baumannii from Singapore , 2007 .
[357] Chul Hee Choi,et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. , 2007, The Journal of antimicrobial chemotherapy.
[358] Y. Carmeli,et al. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. , 2007, The Journal of antimicrobial chemotherapy.
[359] G. Biancofiore,et al. Colistin, meropenem and rifampin in a combination therapy for multi-drug-resistant Acinetobacter baumannii multifocal infection. A case report. , 2007, Minerva anestesiologica.
[360] S. Pournaras,et al. Identification of a novel bla(OXA-51) variant, bla(OXA-92), from a clinical isolate of Acinetobacter baumannii. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[361] R. Morgan,et al. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. , 2007, Journal of medical microbiology.
[362] Lu-Cheng Kuo,et al. Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[363] P. Nordmann,et al. Genetics and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene blaOXA-23 in Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.
[364] F. Romesberg,et al. Controlling Mutation: Intervening in Evolution as a Therapeutic Strategy , 2007, Critical reviews in biochemistry and molecular biology.
[365] L. Hsu,et al. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. , 2007, The Journal of antimicrobial chemotherapy.
[366] T. Tsaganos,et al. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin. , 2007, International journal of antimicrobial agents.
[367] L. Dijkshoorn,et al. Horizontal Gene Transfer in a Polyclonal Outbreak of Carbapenem-Resistant Acinetobacter baumannii , 2006, Journal of Clinical Microbiology.
[368] Chieh-Chen Huang,et al. Predictive biomarkers for drug-resistant Acinetobacter baumannii isolates with bla(TEM-1), AmpC-type bla and integrase 1 genotypes. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[369] B. Charra,et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. , 2006, The Journal of infection.
[370] M. Galas,et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas , 2006, Antimicrobial Agents and Chemotherapy.
[371] F. Budak,et al. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. , 2006, The Journal of antimicrobial chemotherapy.
[372] J. Quinn,et al. Multicity Outbreak of Carbapenem-Resistant Acinetobacter baumannii Isolates Producing the Carbapenemase OXA-40 , 2006, Antimicrobial Agents and Chemotherapy.
[373] J. Desenclos,et al. VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France , 2006, Emerging Infectious Diseases.
[374] M. Kaufmann,et al. Identification of Acinetobacter baumannii by Detection of the blaOXA-51-like Carbapenemase Gene Intrinsic to This Species , 2006, Journal of Clinical Microbiology.
[375] J. Desenclos,et al. VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. , 2006, Emerging infectious diseases.
[376] Stephen Lory,et al. A Virulence Locus of Pseudomonas aeruginosa Encodes a Protein Secretion Apparatus , 2006, Science.
[377] A. Oliver,et al. OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain , 2006, Antimicrobial Agents and Chemotherapy.
[378] A. Maniatis,et al. VIM-1 Metallo-β-lactamase in Acinetobacter baumannii , 2006, Emerging infectious diseases.
[379] A. Gales,et al. Dissemination of IMP-1 Metallo-β-Lactamase–Producing Acinetobacter Species in a Brazilian Teaching Hospital , 2006, Infection Control & Hospital Epidemiology.
[380] P. Higgins,et al. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. , 2006, The Journal of antimicrobial chemotherapy.
[381] M. Kaufmann,et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. , 2006, FEMS microbiology letters.
[382] F. Can,et al. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. , 2006, International journal of antimicrobial agents.
[383] P. Fournier,et al. The epidemiology and control of Acinetobacter baumannii in health care facilities. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[384] A. Maniatis,et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. , 2006, The Journal of antimicrobial chemotherapy.
[385] D. Raoult,et al. Sequencing of the rpoB Gene and Flanking Spacers for Molecular Identification of Acinetobacter Species , 2006, Journal of Clinical Microbiology.
[386] P. Nordmann,et al. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[387] W. Nelson,et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[388] J. Weissenbach,et al. Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii , 2006, PLoS genetics.
[389] S. Shoham,et al. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis. , 2005, The Journal of infection.
[390] G. Bou,et al. Cloning and Functional Analysis of the Gene Encoding the 33- to 36-Kilodalton Outer Membrane Protein Associated with Carbapenem Resistance in Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.
[391] D. Vallenet,et al. Channel Formation by CarO, the Carbapenem Resistance-Associated Outer Membrane Protein of Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.
[392] G. Rossolini,et al. Novel Acquired Metallo-β-Lactamase Gene, blaSIM-1, in a Class 1 Integron from Acinetobacter baumannii Clinical Isolates from Korea , 2005, Antimicrobial Agents and Chemotherapy.
[393] J. Chen,et al. AbeM, an H+-Coupled Acinetobacter baumannii Multidrug Efflux Pump Belonging to the MATE Family of Transporters , 2005, Antimicrobial Agents and Chemotherapy.
[394] J. Claverie,et al. Characterization of the Naturally Occurring Oxacillinase of Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.
[395] J. Pagés,et al. Identification of an OprD homologue in Acinetobacter baumannii. , 2005, Journal of proteome research.
[396] P. Nordmann,et al. Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-23 in a Tertiary Care Hospital of Papeete, French Polynesia , 2005, Journal of Clinical Microbiology.
[397] E. Nicastri,et al. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[398] Chul Hee Choi,et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells , 2005, Cellular microbiology.
[399] P. Nordmann,et al. Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.
[400] L. Rice,et al. Identification of a New Allelic Variant of the Acinetobacter baumannii Cephalosporinase , ADC-7-Lactamase : Defining a Unique Family of Class C Enzymes ‡ , 2005 .
[401] P. Nordmann,et al. Genetic Environment and Expression of the Extended-Spectrum β-Lactamase blaPER-1 Gene in Gram-Negative Bacteria , 2005, Antimicrobial Agents and Chemotherapy.
[402] A. Viale,et al. Acquisition of Resistance to Carbapenems in Multidrug-Resistant Clinical Strains of Acinetobacter baumannii: Natural Insertional Inactivation of a Gene Encoding a Member of a Novel Family of β-Barrel Outer Membrane Proteins , 2005, Antimicrobial Agents and Chemotherapy.
[403] M. Vaneechoutte,et al. Species-Level Identification of Isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex by Sequence Analysis of the 16S-23S rRNA Gene Spacer Region , 2005, Journal of Clinical Microbiology.
[404] S. H. Lee,et al. Investigation of a nosocomial outbreak of Acinetobacter baumannii producing PER-1 extended-spectrum beta-lactamase in an intensive care unit. , 2005, The Journal of hospital infection.
[405] P. Nordmann,et al. OXA-58, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii , 2005, Antimicrobial Agents and Chemotherapy.
[406] G. Reid. The importance of guidelines in the development and application of probiotics. , 2005, Current pharmaceutical design.
[407] S. Amyes,et al. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[408] J. Malone,et al. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. , 2004, MMWR. Morbidity and mortality weekly report.
[409] L. Dijkshoorn,et al. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. , 2004, Journal of medical microbiology.
[410] C. Cabellos,et al. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. , 2004, The Journal of antimicrobial chemotherapy.
[411] J. Pachón,et al. Activity of Tigecycline (GAR-936) against Acinetobacter baumannii Strains, Including Those Resistant to Imipenem , 2004, Antimicrobial Agents and Chemotherapy.
[412] P. Higgins,et al. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. , 2004, Journal of Antimicrobial Chemotherapy.
[413] P. Courvalin,et al. Expression of the RND-Type Efflux Pump AdeABC in Acinetobacter baumannii Is Regulated by the AdeRS Two-Component System , 2004, Antimicrobial Agents and Chemotherapy.
[414] Y. Arakawa,et al. Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. , 2004, Journal of clinical microbiology.
[415] S. Zanetti,et al. PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[416] Y. Arakawa,et al. Spread of Novel Aminoglycoside Resistance Gene aac(6′)-Iad among Acinetobacter Clinical Isolates in Japan , 2004, Antimicrobial Agents and Chemotherapy.
[417] E. Nelson,et al. Genetic Environment and Transcription of ampC in an Acinetobacter baumannii Clinical Isolate , 2004, Antimicrobial Agents and Chemotherapy.
[418] E. Hultén,et al. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. , 2004, MMWR. Morbidity and mortality weekly report.
[419] L. Actis,et al. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. , 2003, Microbiology.
[420] N. Caroff,et al. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. , 2003, The Journal of antimicrobial chemotherapy.
[421] J. Ruiz,et al. Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii. , 2003, The Journal of antimicrobial chemotherapy.
[422] D. Landman,et al. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[423] J. Ruiz,et al. Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii , 2003, Antimicrobial Agents and Chemotherapy.
[424] P. Turner,et al. The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[425] D. Rimar,et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. , 2003, The Journal of hospital infection.
[426] A. Cheng,et al. Significance of Genomic DNA Group Delineation in Comparative Studies of Antimicrobial Susceptibility of Acinetobacter spp , 2003, Antimicrobial Agents and Chemotherapy.
[427] P. Nordmann,et al. Genetic and Functional Analysis of the Chromosome-Encoded Carbapenem-Hydrolyzing Oxacillinase OXA-40 of Acinetobacter baumannii , 2003, Antimicrobial Agents and Chemotherapy.
[428] Ronald N. Jones,et al. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. , 2003, Diagnostic microbiology and infectious disease.
[429] J. Rodríguez-Baño,et al. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[430] G. Rossolini,et al. Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes. , 2002, The Journal of antimicrobial chemotherapy.
[431] J. Ruiz,et al. Characterization of an integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii. , 2002, Microbial drug resistance.
[432] S. Magnet,et al. Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454 , 2001, Antimicrobial Agents and Chemotherapy.
[433] A. Yamaguchi,et al. Novel Macrolide-Specific ABC-Type Efflux Transporter inEscherichia coli , 2001, Journal of bacteriology.
[434] P. Savelkoul,et al. Antibiotic Resistance Is a Major Risk Factor for Epidemic Behavior of Acinetobacter baumannii , 2001, Infection Control & Hospital Epidemiology.
[435] N. Woodford,et al. IMP-4, a Novel Metallo-β-Lactamase from Nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998 , 2001, Antimicrobial Agents and Chemotherapy.
[436] N. Woodford,et al. Characterization of OXA-25, OXA-26, and OXA-27, Molecular Class D β-Lactamases Associated with Carbapenem Resistance in Clinical Isolates of Acinetobacter baumannii , 2001, Antimicrobial Agents and Chemotherapy.
[437] K. Towner,et al. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. , 2001, Journal of medical microbiology.
[438] G. Bou,et al. Characterization of a Nosocomial Outbreak Caused by a Multiresistant Acinetobacter baumannii Strain with a Carbapenem-Hydrolyzing Enzyme: High-Level Carbapenem Resistance inA. baumannii Is Not Due Solely to the Presence of β-Lactamases , 2000, Journal of Clinical Microbiology.
[439] A. Oliver,et al. OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumanniiClinical Strain , 2000, Antimicrobial Agents and Chemotherapy.
[440] G. Cornaglia,et al. Characterization of the Metallo-β-Lactamase Determinant of Acinetobacter baumannii AC-54/97 Reveals the Existence of blaIMP Allelic Variants Carried by Gene Cassettes of Different Phylogeny , 2000, Antimicrobial Agents and Chemotherapy.
[441] G. Bou,et al. Cloning, Nucleotide Sequencing, and Analysis of the Gene Encoding an AmpC β-Lactamase in Acinetobacter baumannii , 2000, Antimicrobial Agents and Chemotherapy.
[442] L R Bernstein,et al. Mechanisms of therapeutic activity for gallium. , 1998, Pharmacological reviews.
[443] C. Vandenbroucke-Grauls,et al. Comparison of Amplified Ribosomal DNA Restriction Analysis, Random Amplified Polymorphic DNA Analysis, and Amplified Fragment Length Polymorphism Fingerprinting for Identification ofAcinetobacter Genomic Species and Typing ofAcinetobacter baumannii , 1998, Journal of Clinical Microbiology.
[444] J. Barr,et al. In-vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii. , 1998, The Journal of antimicrobial chemotherapy.
[445] J. Ruiz,et al. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived beta-lactamase in Acinetobacter baumannii , 1997, Antimicrobial agents and chemotherapy.
[446] J. Songer,et al. Bacterial phospholipases and their role in virulence. , 1997, Trends in microbiology.
[447] M. Kaufmann,et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods , 1996, Journal of clinical microbiology.
[448] E Bergogne-Bérézin,et al. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features , 1996, Clinical microbiology reviews.
[449] J. Ruiz,et al. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii , 1995, Antimicrobial agents and chemotherapy.
[450] P. Courvalin,et al. Detection of aac(6')-I genes in amikacin-resistant Acinetobacter spp. by PCR , 1994, Antimicrobial Agents and Chemotherapy.
[451] K. Lewis,et al. Emr, an Escherichia coli locus for multidrug resistance. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[452] W. Opferkuch,et al. Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins. , 1991, Chemotherapy.